Provider
Opzelura (ruxolitinib) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Dec 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Dec 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Step Therapy, Quantity Limit
Program effective Date: Jan 01, 2026
Step Therapy, Quantity Limit
Program effective Date: Jul 01, 2025
Quantity Limit
Program effective Date: Jun 01, 2024
Quantity Limit
Program effective Date: Jul 01, 2024
Step Therapy, Quantity Limit
Program effective Date: Dec 01, 2025
Prior Authorization
Program effective Date: Jan 01, 2026